BDSI - バイオデリバリ―・サイエンシズ・インタ―ナショナル (BioDelivery Sciences International Inc.) バイオデリバリ―・サイエンシズ・インタ―ナショナル

 BDSIのチャート


 BDSIの企業情報

symbol BDSI
会社名 BioDelivery Sciences International Inc (バイオデリバリ―・サイエンシズ・インタ―ナショナル)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 バイオデリバリ・サイエンシズ・インターナショナル(BioDelivery Sciences International Inc.)は専門製薬会社であり、自社独力或いは第三者との提携で、医療ニーズに応じた治療薬の開発・商業化に従事する。同社は主に疼痛管理とがん補助療法分野向けの医薬品を開発していた。またはそれを開発している。同社は頬粘膜に作用する小・侵食性高分子フィルムである生体侵食性粘膜接着性システム(BEMA)技術を利用して薬品と薬品候補の製剤を行う。同社の米国食品医薬品局(FDA)認可の製品「ONSOLIS」及びその薬品候補のパイプラインはBEMA技術を利用している。   バイオデリバリ―・サイエンシズ・インタ―ナショナルは米国のバイオ医薬品メ―カ―。独自に又は他の医薬品メ―カ―と共同で、実績のある治療薬の新しいアプリケ―ションを開発、製品化。疼痛管理と依存の分野を主とした医薬品を開発。製品を開発する際に、独自開発で特許取得済みの生体内分解性粘膜付着性(BEMA)ドラッグデリバリ―技術を応用する。   BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.
本社所在地 4131 ParkLake Avenue Suite 225 Raleigh NC 27612 USA
代表者氏名 Frank E. O'Donnell フランク・E・オドネル
代表者役職名 Executive Chairman of the Board 取締役会長
電話番号 +1 919-582-9050
設立年月日 35431
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 116人
url www.bdsi.com
nasdaq_url https://www.nasdaq.com/symbol/bdsi
adr_tso
EBITDA EBITDA(百万ドル) -33.52800
終値(lastsale) 3.26
時価総額(marketcap) 194162910.5
時価総額 時価総額(百万ドル) 202.50120
売上高 売上高(百万ドル) 47.22100
企業価値(EV) 企業価値(EV)(百万ドル) 196.17320
当期純利益 当期純利益(百万ドル) -48.64000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 BioDelivery Sciences International Inc. revenues decreased 39% to $23.5M. Net loss totaled $20.5M vs. income of $33.4M. Revenues reflect Contract revenues decrease of 95% to $1M Product royalty revenues decrease of 20% to $1.8M Research and development reimbursements decrease from $267K to $0K. Net loss reflects Bargain purchase gain decrease from $27.3M (income) to $0K.

 BDSIのテクニカル分析


 BDSIのニュース

   BioDelivery Sciences: Clinic-To-Market Transition Problem  2021/05/28 23:25:57 Seeking Alpha
   William Blair Research Analysts Decrease Earnings Estimates for BioDelivery Sciences International, Inc. (NASDAQ:BDSI)  2021/05/12 06:58:45 Dakota Financial News
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Investment analysts at William Blair reduced their Q2 2021 earnings per share (EPS) estimates for shares of BioDelivery Sciences International in a note issued to investors on Thursday, May 6th. William Blair analyst T. Lugo now expects that the specialty pharmaceutical company will earn $0.05 per share for the []
   Biodelivery Sciences International Shares Close the Day 11.9% Higher - Daily Wrap  2021/05/11 22:30:00 Kwhen Finance
Biodelivery Sciences International (BDSI) shares closed today 11.9% higher than it did at the end of yesterday. The stock is currently down 15.2% year-to-date, down 18.2% over the past 12 months, and up 76.2% over the past five years. Today, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 1.5%. Trading Activity Shares traded as high as $3.65 and as low as $3.06 this week.Shares closed 3e+1% below its 52-week high and 2e+1% above its 52-week low.Trading volume this week was 23.6% lower than the 10-day average and 11.7% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 55.2% The company's stock price performance over the past 12 months lags the peer average by 184.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   James Vollins Sells 8,303 Shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Stock  2021/02/10 10:58:56 Watchlist News
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) insider James Vollins sold 8,303 shares of BioDelivery Sciences International stock in a transaction dated Thursday, February 4th. The shares were sold at an average price of $3.97, for a total value of $32,962.91. Following the completion of the transaction, the insider now owns 3,833 shares of the company’s stock, […]
   BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Insider James Vollins Sells 3,833 Shares of Stock  2021/02/09 10:38:41 Watchlist News
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) insider James Vollins sold 3,833 shares of BioDelivery Sciences International stock in a transaction dated Monday, February 8th. The stock was sold at an average price of $4.16, for a total transaction of $15,945.28. Following the sale, the insider now owns 3,833 shares of the company’s stock, valued at $15,945.28. […]
   Insider Selling: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Insider Sells $13,390.20 in Stock  2021/02/05 11:37:38 Watchlist News
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) insider Mary Theresa Coelho sold 3,460 shares of the company’s stock in a transaction on Monday, February 1st. The shares were sold at an average price of $3.87, for a total transaction of $13,390.20. Following the transaction, the insider now owns 34,079 shares of the company’s stock, valued at $131,885.73. […]
   Mary Theresa Coelho Sells 6,462 Shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Stock  2021/01/21 00:17:26 Watchlist News
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) insider Mary Theresa Coelho sold 6,462 shares of the business’s stock in a transaction dated Tuesday, January 19th. The shares were sold at an average price of $4.32, for a total transaction of $27,915.84. Following the completion of the sale, the insider now owns 30,351 shares in the company, valued […]
   Musculoskeletal Pains Market - Insights On Scope 2025 | Zogenix, Inc., Dainippon Sumitomo Pharma Co., Ltd., BioDelivery Sciences International, Inc.  2021/01/06 10:16:44 OpenPR
Global Musculoskeletal Pains Market: Snapshot Musculoskeletal pain is pain that affects bones, muscles, or the various types of connective tissues that hold the two together, such as tendons and ligaments. This type of pain can occur due to overuse or repetitive
   Insider Selling: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Insider Sells $13,390.20 in Stock  2021/02/05 11:37:38 Watchlist News
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) insider Mary Theresa Coelho sold 3,460 shares of the company’s stock in a transaction on Monday, February 1st. The shares were sold at an average price of $3.87, for a total transaction of $13,390.20. Following the transaction, the insider now owns 34,079 shares of the company’s stock, valued at $131,885.73. […]
   Mary Theresa Coelho Sells 6,462 Shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Stock  2021/01/21 00:17:26 Watchlist News
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) insider Mary Theresa Coelho sold 6,462 shares of the business’s stock in a transaction dated Tuesday, January 19th. The shares were sold at an average price of $4.32, for a total transaction of $27,915.84. Following the completion of the sale, the insider now owns 30,351 shares in the company, valued […]
   Musculoskeletal Pains Market - Insights On Scope 2025 | Zogenix, Inc., Dainippon Sumitomo Pharma Co., Ltd., BioDelivery Sciences International, Inc.  2021/01/06 10:16:44 OpenPR
Global Musculoskeletal Pains Market: Snapshot Musculoskeletal pain is pain that affects bones, muscles, or the various types of connective tissues that hold the two together, such as tendons and ligaments. This type of pain can occur due to overuse or repetitive
   BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Insider James Vollins Sells 20,320 Shares  2020/12/19 11:28:41 Watchlist News
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) insider James Vollins sold 20,320 shares of the firm’s stock in a transaction that occurred on Monday, December 14th. The shares were sold at an average price of $4.46, for a total transaction of $90,627.20. Following the transaction, the insider now owns 20,320 shares in the company, valued at approximately […]
   BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference  2020/11/20 13:30:00 GlobeNewswire
RALEIGH, N.C., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical…

 関連キーワード  (医薬品 米国株 バイオデリバリ―・サイエンシズ・インタ―ナショナル BDSI BioDelivery Sciences International Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)